Medpace Holdings, Inc.
DE ˙ DB ˙ US58506Q1094
394,00 € ↑6,10 (1,57%)
2026-06-04
CENA AKCJI
SecurityDE:01P / Medpace Holdings, Inc.
InstitutionHardy Reed LLC
Latest Disclosed Ownership632 shares
Latest Disclosed Value $ 303,481
Hardy Reed LLC reports 0.63% decrease in ownership of 01P / Medpace Holdings, Inc.

On April 28, 2026 - Hardy Reed LLC filed a 13F-HR form disclosing ownership of 632 shares of Medpace Holdings, Inc. (DE:01P) valued at $260,447 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 636 shares of Medpace Holdings, Inc.. This represents a change in shares of -0.63% during the quarter. The current value of the position is $249,008 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F MEDPACE HLDGS COM 58506Q109 632 -4 -0.63 303 -15.13 0.0221
2026-02-06 2025-12-31 13F MEDPACE HLDGS COM 58506Q109 636 4 0.63 357 10.19 0.0255
2025-11-07 2025-09-30 13F MEDPACE HLDGS COM 58506Q109 632 -105 -14.25 325 40.26 0.0239
2025-07-23 2025-06-30 13F MEDPACE HLDGS COM 58506Q109 737 0 0.00 231 3.13 0.0185
2025-05-02 2025-03-31 13F MEDPACE HLDGS COM 58506Q109 737 0 0.00 225 -8.20 0.0198
2025-02-03 2024-12-31 13F MEDPACE HLDGS COM 58506Q109 737 0 0.00 245 -0.81 0.0216
2024-11-13 2024-09-30 13F MEDPACE HLDGS COM 58506Q109 737 0 0.00 246 -18.81 0.0220
2024-08-12 2024-06-30 13F MEDPACE HLDGS COM 58506Q109 737 -130 -14.99 304 -13.43 0.0305
2024-05-02 2024-03-31 13F MEDPACE HLDGS COM 58506Q109 867 -166 -16.07 350 10.76 0.0435
2024-02-13 2023-12-31 13F/A-1 MEDPACE HLDGS COM 58506Q109 1,033 -5 -0.48 317 25.90 0.0429
2024-01-24 2023-12-31 13F MEDPACE HLDGS COM 58506Q109 1,033 -5 317 0.0429
2023-11-09 2023-09-30 13F MEDPACE HLDGS COM 58506Q109 1,038 0 0.00 251 0.80 0.0456
2023-08-14 2023-06-30 13F MEDPACE HLDGS COM 58506Q109 1,038 1,038 249 0.0439
2022-07-28 2022-06-30 13F MEDPACE HLDGS COM 58506Q109 0 -827 -100.00 0 -100.00
2022-04-28 2022-03-31 13F MEDPACE HLDGS COM 58506Q109 827 827 135 0.0247
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.